发明申请
US20220211621A1 LIPOSOMAL SUSTAINED-RELEASE COMPOSITIONS CONTAINING A THERAPEUTIC DRUG AND USE THEREOF
有权
基本信息:
- 专利标题： LIPOSOMAL SUSTAINED-RELEASE COMPOSITIONS CONTAINING A THERAPEUTIC DRUG AND USE THEREOF
- 申请号：US17605367 申请日：2020-04-25
- 公开(公告)号：US20220211621A1 公开(公告)日：2022-07-07
- 发明人： Yun-Long TSENG , Hsin-Yi CHIU
- 申请人： TLC BIOPHARMACEUTICALS, INC. , TAIWAN LIPOSOME CO., LTD.
- 申请人地址： US CA South San Francisco; TW Taipei City
- 专利权人： TLC BIOPHARMACEUTICALS, INC.,TAIWAN LIPOSOME CO., LTD.
- 当前专利权人： TLC BIOPHARMACEUTICALS, INC.,TAIWAN LIPOSOME CO., LTD.
- 当前专利权人地址： US CA South San Francisco; TW Taipei City
- 国际申请： PCT/US2020/029980 WO 20200425
- 主分类号： A61K9/127
- IPC分类号： A61K9/127 ; A61K47/28 ; A61K47/24 ; A61K31/4168 ; A61K31/192 ; A61K31/405 ; A61K31/135 ; A61K31/40 ; A61K31/196 ; A61K31/485 ; A61K31/616 ; A61K31/573 ; A61K31/5415 ; A61K31/245 ; A61K31/445 ; A61K31/167 ; A61K31/085 ; A61K31/5513 ; A61K31/5517 ; A61K31/045 ; A61K31/46 ; A61K31/439 ; A61K31/4745 ; A61K31/137 ; A61K31/397
摘要：
Provided is a liposomal sustained-release composition comprising a therapeutic agent and one or more lipids. The therapeutic agent and total lipids are present in the liposomal sustained-released composition at a predetermined ratio. The liposomal sustained-release composition achieves a desired therapeutic effect while avoiding undesired side effects. The therapeutic agent is stably entrapped in the liposomes of the composition and sustainably released therefrom. This liposomal formulation for the therapeutic agent demonstrates an improved release profile.
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K9/00 | 以特殊物理形状为特征的医药配制品 |
| --------A61K9/10 | .分散液；乳剂 |
| ----------A61K9/127 | ..脂质体 |